Skip to main content

Bronchitis News

Researchers Compare Race-Based, Race-Neutral Lung Function Equations

TUESDAY, May 21, 2024 – The use of race-based and race-neutral equations for lung-function testing generate similarly accurate predictions of respiratory outcomes, but differ in terms of disease...

A Quarter of Americans Breathe 'Unhealthy Air,' Report Shows

TUESDAY, Feb. 13, 2024 – Few can forget the haunting images of New York City bathed in a thick orange smog after smoke from Canadian wildfires swept southward last summer. Now, a new report from the...

Wildfire Smoke Pollution a Growing Global Threat

THURSDAY, Sept. 21, 2023 – More people around the world are exposed to wildfire smoke that has the potential to harm human health, and their numbers are growing, new research finds. More than 2...

Wildfire Smoke Is Reversing Recent Clean-Air Gains Across the U.S.

WEDNESDAY, Sept. 20, 2023 – When Canadian wildfire smoke shrouded the New York City skyline and spread to parts of New England this summer, millions of East Coast residents saw firsthand just how...

Cleaning Products, Even Green Ones, Emit Unhealthy Toxins

THURSDAY, Sept. 14, 2023 – Everyday products used for cleaning or freshening the air may release hundreds of hazardous volatile organic compounds, according to new research. Both conventional and...

E-Cigarette Use Tied to Respiratory Symptoms in Young Adults

FRIDAY, Aug. 18, 2023 – Electronic cigarette use in young adults is associated with self-reported respiratory symptoms, according to a study published online Aug. 15 in Thorax. Alayna P. Tackett,...

Vaping Can Hamper Breathing in the Young

WEDNESDAY, Aug. 16, 2023 – When teens vape, their lungs pay a price, researchers report. The warning stems from a detailed analysis of smoking habit histories shared by just over 2,000 U.S. teens...

Race-Specific Approach to Spirometry Disadvantages Black Patients

WEDNESDAY, July 26, 2023 – A race-specific approach to spirometry interpretation results in a lower lung allocation score (LAS) for Black patients and a higher LAS for White patients, according to a...

Once Again, Smoke From Canadian Wildfires Envelops Many American Cities

THURSDAY, June 29, 2023 – For the second time this month, massive plumes of smoke from hundreds of out-of-control Canadian wildfires are polluting much of America's air. Among the major U.S. cities n...

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD

London UK – 18 September 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single i...

FDA Medwatch Alert: Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects

ISSUE: FDA approved changes to the labels of fluoroquinolone antibacterial drugs for systemic use (i.e., taken by mouth or by injection). Includes the following currently available fluoroquinolones:...

FDA Medwatch Alert: Fluoroquinolone Antibacterial Drugs: Drug Safety Communication - FDA Advises Restricting Use for Certain Uncomplicated Infections

ISSUE: FDA is advising that the serious side effects associated with fluoroquinolone antibacterial drugs generally outweigh the benefits for patients with sinusitis, bronchitis, and uncomplicated...

FDA Approves Tudorza Pressair to Treat Chronic Obstructive Pulmonary Disease

July 23, 2012 – The U.S. Food and Drug Administration today approved Tudorza Pressair (aclidinium bromide) for the long-term maintenance treatment of bronchospasm (narrowing of the airways in the...

FDA Approves Arcapta Neohaler to treat Chronic Obstructive Pulmonary Disease

The U.S. Food and Drug Administration today approved Arcapta Neohaler (indacaterol inhalation powder) for the long term, once-daily maintenance bronchodilator treatment of airflow obstruction in...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

amoxicillin, doxycycline, Mucinex, azithromycin, Bactrim, Cipro, ciprofloxacin, Zithromax, Levaquin, view more... Augmentin, erythromycin, levofloxacin, clarithromycin, guaifenesin, cefdinir, sulfamethoxazole / trimethoprim, amoxicillin / clavulanate, Bactrim DS, tetracycline, Rocephin